Skip to main content
Top
Published in: European Journal of Nutrition 1/2019

01-02-2019 | Original Contribution

Postoperative intermittent fasting prevents hippocampal oxidative stress and memory deficits in a rat model of chronic cerebral hypoperfusion

Authors: Yuan Hu, Miao Zhang, Yunyun Chen, Ying Yang, Jun-Jian Zhang

Published in: European Journal of Nutrition | Issue 1/2019

Login to get access

Abstract

Purpose

Whether intermittent fasting (IF) treatment after stroke can prevent its long-term detrimental effects remains unknown. Here, we investigate the effects of postoperative IF on cognitive deficits and its underlying mechanisms in a permanent two-vessel occlusion (2VO) vascular dementia rat model.

Methods

Rats were subjected to either IF or ad libitum feeding 1 week after 2VO surgery. The cognition of rats was assessed using the novel object recognition (NOR) task and Morris water maze (MWM) 8 weeks after surgery. After behavioral testing, hippocampal malondialdehyde (MDA) and glutathione (GSH) concentrations, superoxide dismutase (SOD) activity, gene expression of antioxidative enzymes, inflammatory protein levels, and microglia density were determined.

Results

Postoperative IF significantly ameliorated the cognitive performance of 2VO rats in the NOR and MWM tests. Cognitive enhancement paralleled preservation of the PSD95 and BDNF levels in the 2VO rat hippocampus. Mechanistically, postoperative IF mitigated hippocampal oxidative stress in 2VO rats, as indicated by the reduced MDA concentration and mRNA and the protein levels of the reactive oxygen species-generating enzyme nicotinamide adenine dinucleotide phosphate oxidase 1. IF treatment also preserved the GSH level and SOD activity, as well as the levels of their upstream regulating enzymes, resulting in preserved antioxidative capability. In addition, postoperative IF prevented hippocampal microglial activation and elevation of sphingosine 1-phosphate receptor 1 and inflammatory cytokines in 2VO rats.

Conclusions

Our results suggest that postoperative IF suppresses neuroinflammation and oxidative stress induced by chronic cerebral ischemia, thereby preserving cognitive function in a vascular dementia rat model.
Appendix
Available only for authorised users
Literature
1.
go back to reference Gorelick PB et al (2011) Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association. Stroke 42:2672–2713CrossRefPubMedPubMedCentral Gorelick PB et al (2011) Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association. Stroke 42:2672–2713CrossRefPubMedPubMedCentral
2.
go back to reference Yang T, Sun Y, Lu Z, Leak RK, Zhang F (2017) The impact of cerebrovascular aging on vascular cognitive impairment and dementia. Ageing Res Rev 34:15–29CrossRefPubMed Yang T, Sun Y, Lu Z, Leak RK, Zhang F (2017) The impact of cerebrovascular aging on vascular cognitive impairment and dementia. Ageing Res Rev 34:15–29CrossRefPubMed
3.
go back to reference Farkas E, Luiten PG, Bari F (2007) Permanent, bilateral common carotid artery occlusion in the rat: a model for chronic cerebral hypoperfusion-related neurodegenerative diseases. Brain Res Rev 54:162–180CrossRefPubMed Farkas E, Luiten PG, Bari F (2007) Permanent, bilateral common carotid artery occlusion in the rat: a model for chronic cerebral hypoperfusion-related neurodegenerative diseases. Brain Res Rev 54:162–180CrossRefPubMed
4.
go back to reference Du SQ, Wang XR, Xiao LY, Tu JF, Zhu W, He T, Liu CZ (2017) Molecular mechanisms of vascular dementia: what can be learned from animal models of chronic cerebral hypoperfusion? Mol Neurobiol 54:3670–3682CrossRefPubMed Du SQ, Wang XR, Xiao LY, Tu JF, Zhu W, He T, Liu CZ (2017) Molecular mechanisms of vascular dementia: what can be learned from animal models of chronic cerebral hypoperfusion? Mol Neurobiol 54:3670–3682CrossRefPubMed
5.
go back to reference McCay CM, Crowell MF, Maynard LA (1989) The effect of retarded growth upon the length of life span and upon the ultimate body size. 1935. Nutrition 5:155–171 (discussion 172) PubMed McCay CM, Crowell MF, Maynard LA (1989) The effect of retarded growth upon the length of life span and upon the ultimate body size. 1935. Nutrition 5:155–171 (discussion 172) PubMed
7.
go back to reference Arumugam TV, Phillips TM, Cheng A, Morrell CH, Mattson MP, Wan R (2010) Age and energy intake interact to modify cell stress pathways and stroke outcome. Ann Neurol 67:41–52CrossRefPubMedPubMedCentral Arumugam TV, Phillips TM, Cheng A, Morrell CH, Mattson MP, Wan R (2010) Age and energy intake interact to modify cell stress pathways and stroke outcome. Ann Neurol 67:41–52CrossRefPubMedPubMedCentral
8.
go back to reference Duan W, Mattson MP (1999) Dietary restriction and 2-deoxyglucose administration improve behavioral outcome and reduce degeneration of dopaminergic neurons in models of Parkinson’s disease. J Neurosci Res 57:195–206CrossRefPubMed Duan W, Mattson MP (1999) Dietary restriction and 2-deoxyglucose administration improve behavioral outcome and reduce degeneration of dopaminergic neurons in models of Parkinson’s disease. J Neurosci Res 57:195–206CrossRefPubMed
9.
go back to reference Halagappa VK, Guo Z, Pearson M, Matsuoka Y, Cutler RG, Laferla FM, Mattson MP (2007) Intermittent fasting and caloric restriction ameliorate age-related behavioral deficits in the triple-transgenic mouse model of Alzheimer’s disease. Neurobiol Dis 26:212–220CrossRefPubMed Halagappa VK, Guo Z, Pearson M, Matsuoka Y, Cutler RG, Laferla FM, Mattson MP (2007) Intermittent fasting and caloric restriction ameliorate age-related behavioral deficits in the triple-transgenic mouse model of Alzheimer’s disease. Neurobiol Dis 26:212–220CrossRefPubMed
10.
go back to reference Maswood N et al (2004) Caloric restriction increases neurotrophic factor levels and attenuates neurochemical and behavioral deficits in a primate model of Parkinson’s disease. Proc Natl Acad Sci USA 101:18171–18176CrossRefPubMedPubMedCentral Maswood N et al (2004) Caloric restriction increases neurotrophic factor levels and attenuates neurochemical and behavioral deficits in a primate model of Parkinson’s disease. Proc Natl Acad Sci USA 101:18171–18176CrossRefPubMedPubMedCentral
11.
go back to reference Roberge MC, Hotte-Bernard J, Messier C, Plamondon H (2008) Food restriction attenuates ischemia-induced spatial learning and memory deficits despite extensive CA1 ischemic injury. Behav Brain Res 187:123–132CrossRefPubMed Roberge MC, Hotte-Bernard J, Messier C, Plamondon H (2008) Food restriction attenuates ischemia-induced spatial learning and memory deficits despite extensive CA1 ischemic injury. Behav Brain Res 187:123–132CrossRefPubMed
12.
go back to reference Griffioen KJ et al (2013) Dietary energy intake modifies brainstem autonomic dysfunction caused by mutant alpha-synuclein. Neurobiol Aging 34:928–935CrossRefPubMed Griffioen KJ et al (2013) Dietary energy intake modifies brainstem autonomic dysfunction caused by mutant alpha-synuclein. Neurobiol Aging 34:928–935CrossRefPubMed
13.
go back to reference Duan W, Guo Z, Jiang H, Ware M, Li XJ, Mattson MP (2003) Dietary restriction normalizes glucose metabolism and BDNF levels, slows disease progression, and increases survival in huntingtin mutant mice. Proc Natl Acad Sci USA 100:2911–2916CrossRefPubMedPubMedCentral Duan W, Guo Z, Jiang H, Ware M, Li XJ, Mattson MP (2003) Dietary restriction normalizes glucose metabolism and BDNF levels, slows disease progression, and increases survival in huntingtin mutant mice. Proc Natl Acad Sci USA 100:2911–2916CrossRefPubMedPubMedCentral
14.
go back to reference Liu H, Zhang JJ, Li X, Yang Y, Xie XF, Hu K (2015) Post-occlusion administration of sodium butyrate attenuates cognitive impairment in a rat model of chronic cerebral hypoperfusion. Pharmacol Biochem Behav 135:53–59CrossRefPubMed Liu H, Zhang JJ, Li X, Yang Y, Xie XF, Hu K (2015) Post-occlusion administration of sodium butyrate attenuates cognitive impairment in a rat model of chronic cerebral hypoperfusion. Pharmacol Biochem Behav 135:53–59CrossRefPubMed
15.
go back to reference Bevins RA, Besheer J (2006) Object recognition in rats and mice: a one-trial non-matching-to-sample learning task to study ‘recognition memory’. Nat Protoc 1:1306–1311CrossRefPubMed Bevins RA, Besheer J (2006) Object recognition in rats and mice: a one-trial non-matching-to-sample learning task to study ‘recognition memory’. Nat Protoc 1:1306–1311CrossRefPubMed
16.
go back to reference Hu Y, Yang Y, Zhang M, Deng M, Zhang JJ (2017) Intermittent fasting pretreatment prevents cognitive impairment in a rat model of chronic cerebral hypoperfusion. J Nutr 147:1437–1445CrossRefPubMed Hu Y, Yang Y, Zhang M, Deng M, Zhang JJ (2017) Intermittent fasting pretreatment prevents cognitive impairment in a rat model of chronic cerebral hypoperfusion. J Nutr 147:1437–1445CrossRefPubMed
17.
go back to reference Xu Y, Zhang JJ, Xiong L, Zhang L, Sun D, Liu H (2010) Green tea polyphenols inhibit cognitive impairment induced by chronic cerebral hypoperfusion via modulating oxidative stress. J Nutr Biochem 21:741–748CrossRefPubMed Xu Y, Zhang JJ, Xiong L, Zhang L, Sun D, Liu H (2010) Green tea polyphenols inhibit cognitive impairment induced by chronic cerebral hypoperfusion via modulating oxidative stress. J Nutr Biochem 21:741–748CrossRefPubMed
18.
go back to reference Yang Y, Zhang J, Xiong L, Deng M, Wang J, Xin J, Liu H (2015) Cognitive improvement induced by environment enrichment in chronic cerebral hypoperfusion rats: a result of upregulated endogenous neuroprotection? J Mol Neurosci 56:278–289CrossRefPubMed Yang Y, Zhang J, Xiong L, Deng M, Wang J, Xin J, Liu H (2015) Cognitive improvement induced by environment enrichment in chronic cerebral hypoperfusion rats: a result of upregulated endogenous neuroprotection? J Mol Neurosci 56:278–289CrossRefPubMed
19.
20.
21.
go back to reference Davis LM, Pauly JR, Readnower RD, Rho JM, Sullivan PG (2008) Fasting is neuroprotective following traumatic brain injury. J Neurosci Res 86:1812–1822CrossRefPubMed Davis LM, Pauly JR, Readnower RD, Rho JM, Sullivan PG (2008) Fasting is neuroprotective following traumatic brain injury. J Neurosci Res 86:1812–1822CrossRefPubMed
22.
go back to reference Wang J, Fu X, Jiang C, Yu L, Wang M, Han W, Liu L, Wang J (2014) Bone marrow mononuclear cell transplantation promotes therapeutic angiogenesis via upregulation of the VEGF-VEGFR2 signaling pathway in a rat model of vascular dementia. Behav Brain Res 265:171–180CrossRefPubMedPubMedCentral Wang J, Fu X, Jiang C, Yu L, Wang M, Han W, Liu L, Wang J (2014) Bone marrow mononuclear cell transplantation promotes therapeutic angiogenesis via upregulation of the VEGF-VEGFR2 signaling pathway in a rat model of vascular dementia. Behav Brain Res 265:171–180CrossRefPubMedPubMedCentral
23.
go back to reference Li N, Gu Z, Li Y, Fu X, Wang J, Bai H (2015) A modified bilateral carotid artery stenosis procedure to develop a chronic cerebral hypoperfusion rat model with an increased survival rate. J Neurosci Methods 255:115–121CrossRefPubMed Li N, Gu Z, Li Y, Fu X, Wang J, Bai H (2015) A modified bilateral carotid artery stenosis procedure to develop a chronic cerebral hypoperfusion rat model with an increased survival rate. J Neurosci Methods 255:115–121CrossRefPubMed
24.
go back to reference Choi DH et al (2014) NADPH oxidase 1, a novel molecular source of ROS in hippocampal neuronal death in vascular dementia. Antioxid Redox Signal 21:533–550CrossRefPubMedPubMedCentral Choi DH et al (2014) NADPH oxidase 1, a novel molecular source of ROS in hippocampal neuronal death in vascular dementia. Antioxid Redox Signal 21:533–550CrossRefPubMedPubMedCentral
25.
go back to reference Gupta S, Sharma B (2014) Pharmacological modulation of I(1)-imidazoline and alpha2-adrenoceptors in sub acute brain ischemia induced vascular dementia. Eur J Pharmacol 723:80–90CrossRefPubMed Gupta S, Sharma B (2014) Pharmacological modulation of I(1)-imidazoline and alpha2-adrenoceptors in sub acute brain ischemia induced vascular dementia. Eur J Pharmacol 723:80–90CrossRefPubMed
26.
go back to reference O’Sullivan S, Dev KK (2017) Sphingosine-1-phosphate receptor therapies: advances in clinical trials for CNS-related diseases. Neuropharmacology 113:597–607CrossRefPubMed O’Sullivan S, Dev KK (2017) Sphingosine-1-phosphate receptor therapies: advances in clinical trials for CNS-related diseases. Neuropharmacology 113:597–607CrossRefPubMed
Metadata
Title
Postoperative intermittent fasting prevents hippocampal oxidative stress and memory deficits in a rat model of chronic cerebral hypoperfusion
Authors
Yuan Hu
Miao Zhang
Yunyun Chen
Ying Yang
Jun-Jian Zhang
Publication date
01-02-2019
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Nutrition / Issue 1/2019
Print ISSN: 1436-6207
Electronic ISSN: 1436-6215
DOI
https://doi.org/10.1007/s00394-018-1606-4

Other articles of this Issue 1/2019

European Journal of Nutrition 1/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.